Published 4 days ago • loading... • Updated 3 days ago

Sonrai and Plectonic to Advance Cancer Immunotherapies

Summary by Silicon Republic

The collaboration will aim to positively impact treatment across a range of cancers. Read more: Sonrai and Plectonic to advance cancer immunotherapies

2 Articles

All

Left

Center

Right

Silicon Republic

Center

Sonrai and Plectonic to advance cancer immunotherapies

The collaboration will aim to positively impact treatment across a range of cancers. Read more: Sonrai and Plectonic to advance cancer immunotherapies

3 days ago

Read Full Article

european-biotechnology.com

Sonrai and Plectonic Biotech partner to advance cancer immunotherapies - European Biotechnology Magazine

Under a new partnership, Plectonic Biotech will use Sonrai’s AI-powered multi-omics platform to speed up development of its Logybody cancer treatment technology. The approach aims to cut side effects and improve precision. The post Sonrai and Plectonic Biotech partner to advance cancer immunotherapies appeared first on European Biotechnology Magazine.

4 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right